BN
|
MarketsAI Desk•1 views

Snap Jumps 12% on Activist News; McCormick Falls on $45B Deal

Midday trading saw varied stock movements with Snap leading gains at 12% due to an activist investor's stake disclosure. FactSet rose over 4% on better-than-expected earnings and raised guidance. McCormick fell more than 5% after announcing a $45 billion acquisition of Unilever's food business. In the pharmaceutical sector, Apellis and Centessa surged 135% and 45% respectively on acquisition news from Biogen and Eli Lilly. Other notable moves included Constellation Energy's 8% drop on a weak forecast and Marvell's 7% jump from Nvidia's investment.

Ad slot
Snap Jumps 12% on Activist News; McCormick Falls on $45B Deal

In midday trading, several stocks experienced significant volatility driven by earnings reports, activist investments, and major corporate deals. Snap led gains with a 12% increase, while McCormick & Co. dropped over 5% following its announcement to acquire Unilever's food business.

Snap Soars on Activist Investor's Stake

  • Shares of Snap surged 12% after activist investor Irenic disclosed a roughly 2.5% stake in the company.
  • Irenic proposed a plan to enhance shareholder value, including shutting down Snap's augmented reality Specs business.
  • The news was first reported by Bloomberg.

FactSet Rises on Strong Quarterly Results

  • FactSet shares climbed more than 4% following second-quarter adjusted earnings of $4.46 per share, beating the consensus estimate of $4.38.
  • The company lifted its full-year guidance, forecasting adjusted earnings of $17.25 to $17.75 per share.

Symbotic and Rocket Lab Gain from Strategic Agreements

  • Symbotic jumped nearly 5% after announcing a strategic agreement to provide warehouse automation for Associated Wholesale Grocers.
  • Rocket Lab rose about 4% after receiving regulatory approval to acquire optical inter-satellite communication company Mynaric, with completion expected in April.

Constellation Energy Slumps on Disappointing Forecast

  • Constellation Energy shares fell more than 8% after providing a 2026 earnings forecast of $11 to $12 per share, below the consensus estimate of $11.73.
  • CEO Joe Dominguez indicated that new data center deals are anticipated but not yet announced.
Ad slot

McCormick Tumbles on Unilever Acquisition News

  • McCormick & Co. shares dropped over 5% after announcing a cash-and-equity deal to purchase Unilever's food business for nearly $45 billion.
  • Under the deal, McCormick will pay $15.7 billion in cash, and Unilever shareholders will own 55.1% of the combined entity.

Amphenol Gains on Analyst Upgrade

  • Amphenol shares rose more than 2% after Jefferies upgraded the stock to 'buy' from 'hold', citing strong order growth and solid margins.

Big Tech Stocks Rally on Geopolitical Optimism

  • Meta Platforms and Microsoft climbed 4% and 1%, respectively, after a report suggested President Trump aims to end the Iran war without reopening the Strait of Hormuz.
  • Nvidia and Apple advanced 3% and 0.9%, though all four remain lower since the conflict began.

Pharma Stocks Surge on Acquisition Announcements

  • Apellis Pharmaceuticals shares soared 135% after Biogen announced it will acquire the company for $5.6 billion in cash.
  • Centessa Pharmaceuticals surged 45% following Eli Lilly's agreement to buy the company, focusing on neurological conditions.
  • Biogen shares fell over 5% due to the Apellis deal, while Lilly shares gained 2%.

Novo Nordisk Introduces Wegovy Subscription Plan

  • Novo Nordisk shares rose 1% after launching a multimonth subscription plan for its obesity drug Wegovy.
  • Patients can choose three-, six-, or 12-month subscriptions, saving up to $1,200 annually on the injection and $600 on the pill.

Marvell Technology Jumps on Nvidia Investment

  • Marvell shares jumped 7% after Nvidia announced a $2 billion strategic investment.
  • Nvidia plans to integrate Marvell into its AI and radio access network ecosystems.
Ad slot